NARSAD
Donate
HomeAbout UsHow to HelpNews & EventsDisorders & ConditionsResearch Center

» Apply for a Grant
- FAQs
- Young Investigator
- Independent
    Investigator

- Distinguished
    Investigator

- Staglin Award

» Grantee List
- Young Investigators
- Independent
    Investigators

- Distinguished
    Investigators

- Staglin Awards


» Prizes
- Lieber Prize
- Falcone Prize
- Ruane Prize
- Goldman-Rakic Prize
- Freedman Award
- Klerman Award

» For Grantees
- Young Investigator
    Fact Sheet

- Independent
    Investigator
    Fact Sheet

- Distinguished
    Investigator
    Fact Sheet

- Staglin Award
    Fact Sheet


Stay Informed

 
Project Summary

EmailPrint

Kwang-Soo Kim, Ph.D. (Independent Investigator 2003) of Harvard University, notes that in the brain, the neurotransmitter norepinephrine (NE) participates in diverse and essential functions of the nervous system including memory, mood, and cognition and its dysregulation is strongly implicated in major psychiatric illnesses such as mood disorders, schizophrenia, and attention deficit hyperactivity disorder (ADHD). NE neurotransmission is terminated by its rapid reuptake to presynaptic nerve terminals, mediated by the NE transporter (NET). Thus, NET is a key regulator of NE neurotransmission and is a prime target for antidepressant drugs as well as for illicit drugs such as cocaine and amphetamine. Despite its functional importance and clinical significance, molecular mechanisms underlying NET gene expression in the normal and diseased brain are poorly understood. In a previous NARSAD Independent Investigator Award, Dr. Kim successfully studied some aspects of NET gene regulation. He now proposes to characterize transgenic mice as a model of NET gene regulation in the developing and adult brain. He hopes to delineate critical promoter regions that govern in vivo NET gene expression in a specific spatio-temporal fashion and establish invaluable animal models for the further study of NET gene regulation. He will also seek to identify critical transcription factors and investigate their mechanistic role in NET gene expression. Finally, he will attempt to determine if identified novel human-NET (hNET) promoter mutations may be risk factors in psychiatric disorders such as mood disorders and ADHD. He will perform genetic association studies using DNA samples from patients with mood disorders and ADHD and compare them with those from ethnically matched control subjects available in his laboratory. This study will advance basic understanding of NET gene regulation during development at the molecular and systemic level and will directly address whether its functional promoter variations may associate with psychiatric disorders. Thus, the proposed experiments may shed new insights on the biological basis of NE-related psychiatric disorders.

Program Area: MOOD DISORDERS\Unipolar Depression

Search Again

EmailPrint

 

 
Announcements
2008/2009 NARSAD Grant Deadlines:

2008 Young Investigator Earliest Start Date: July 1, 2008

2009 Young Investigator Award Application Deadline: July 25, 2008

2008 Independent Investigator Award Earliest Start Date: September 15, 2008

2008 Staglin Awards Earliest Start Date: September 15, 2008

2009 Independent Investigator Award Application Deadline: March 5, 2009

2009 Distinguished Investigator Earliest Start Date: May 1, 2009

2009 Young Investigator Earliest Start Date: July 1, 2009
NARSAD Award Winners
Latest News from NARSAD

 

 

 
NARSAD 60 Cutter Mill Road, Suite 404, Great Neck, New York 11021 USA     phone (800) 829-8289     fax (516) 487-6930     email info@narsad.org
©NARSAD 2008 | privacy policy | legal notices | disclaimers | sitemap | site help | contact us